1. 286 Phase 2 proof-of-concept trial in progress—lirentelimab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments. (25th January 2023) Authors: Rodriguez, Cristian; Moyer, Anesa; Chang, Alan T; Bortey, Enoch; Paterson, Craig Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗